FDA Adverse Event Injury Summary report: N

STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 10 X 10, FIRM

MDR report key: 11998904 · Received June 15, 2021

Report

Report Number
1000306051-2021-03006
Event Type
Injury
Date Received
June 15, 2021
Date of Event
February 3, 2014
Product Code
FTM
PMA / PMN Number
K070560
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 1

QA INVESTIGATION INTO LOT S11025 RESULTED IN NO REMARKABLE FINDINGS AND NO DEVIATIONS AND NO NONCONFROMANCES REVEALED. 305 DEVICES WERE RELEASED TO FINISHED GOODS. 187 REPORTED AS IMPLANTED 305 HAVE BEEN DISTRIBUTED. NO OTHER COMPLAINTS AGAINST. LOT S11025 WERE REVEALED. LOT S11025 WAS ASEPTICALLY PROCESSED, TERMINALLY STERILIZED AND MET ALL QC RELEASE CRITERIA.

Description of Event or Problem · 1

PATIENT REPRESENTATIVE REPORTED A FEMALE PATIENT HAD STRATTICE, 1010002, IMPLANTED ON (B)(6) 2012 FOR A VENTRAL HERNIA REPAIR. TWO YEARS LATER, (B)(6) 2014, PATIENT RETURNED TO HOSPITAL AND DIAGNOSED WITH INCISIONAL HERNIA. STRATTICE MESH REMOVED AT THAT TIME. LOT# S11025-135.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
899403 STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 10 X 10, FIRM MESH, SURGICAL FTM S11025

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention